Vaccinating patients with inflammatory bowel disease

Gastroenterology and Hepatology

Volumn 12, Issue 9, 2016, Pages 540-546

  Reich, Jason ^a   Wasan, Sharmeel ^a,b   Farraye, Francis A ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health maintenance; Inflammatory bowel disease; Preventive care; Vaccination

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PNEUMOCOCCUS VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE;

ARTICLE; DIPHTHERIA; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; INFLUENZA; MEASLES; MENINGOCOCCOSIS; MUMPS; PAPILLOMAVIRUS INFECTION; PERTUSSIS; RUBELLA; STREPTOCOCCUS PNEUMONIA; TETANUS; TOTAL QUALITY MANAGEMENT; TRAVEL; UNITED STATES; VACCINATION;

EID: 84989208410     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105(6):1231-1238.
2. Esteve M, Saro C, González-Huix F, Suarez F, Forné M, Viver JM. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis. Gut. 2004;53(9):1363-1365.
3. Montiel PM, Solis JA, Chirinos JA, Casis B, Sánchez F, Rodríguez S. Hepatitis B virus reactivation during therapy with etanercept in an HBsAg-negative and anti-HBs-positive patient. Liver Int. 2008;28(5):718-720.
4. Selby L, Kane S, Wilson J, et al. Receipt of preventive health services by IBD patients is significantly lower than by primary care patients. Inflamm Bowel Dis. 2008;14(2):253-258.
5. Kantsø B, Simonsen J, Hoffmann S, Valentiner-Branth P, Petersen AM, Jess T. Inflammatory bowel disease patients are at increased risk of invasive pneumococcal disease: a nationwide Danish cohort study 1977-2013. Am J Gastroenterol. 2015;110(11):1582-1587.
6. Banaszkiewicz A, Targońska B, Kowalska-Duplaga K, et al. Immunogenicity of 13-valent pneumococcal conjugate vaccine in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(7):1607-1614.
7. deBruyn J, Fonseca K, Ghosh S, et al. Immunogenicity of influenza vaccine for patients with inflammatory bowel disease on maintenance infliximab therapy: a randomized trial. Inflamm Bowel Dis. 2016;22(3):638-647.
8. Wasan SK, Zullow S, Berg A, Cheifetz AS, Ganley-Leal L, Farraye FA. Herpes zoster vaccine response in inflammatory bowel disease patients on low-dose immunosuppression. Inflamm Bowel Dis. 2016;22(6):1391-1396.
9. Dotan I, Vigodman S, Malter L, et al. Azathioprine/6-mercaptopurine therapy has no significant effect on cellular or humoral immune responses in patients with inflammatory bowel disease. Gastroenterology. 2007;132:A-51.
10. Wasan SK, Coukos JA, Farraye FA. Vaccinating the inflammatory bowel disease patient: deficiencies in gastroenterologists knowledge. Inflamm Bowel Dis. 2011;17(12):2536-2540.
11. Malhi G, Rumman A, Thanabalan R, et al. Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohns Colitis. 2015;9(6):439-444.
12. Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations - United States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:556-980.
13. Dubinsky M, Rubin D. Cornerstones IBD checklist for monitoring & prevention. Cornerstones Health Inc. http://www.cornerstoneshealth.org/checklist/. Accessed August 16, 2016.
14. Rubin LG, Levin MJ, Ljungman P, et al; Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309-318.
15. Harpaz R, Ortega-Sanchez IR, Seward JF; Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;57(RR-5):1-30.
16. Sands BE, Cuffari C, Katz J, et al. Guidelines for immunizations in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2004;10(5):677-692.
17. Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol. 2004;82(5):488-496.
18. Long MD, Martin C, Sandler RS, Kappelman MD. Increased risk of pneumonia among patients with inflammatory bowel disease. Am J Gastroenterol. 2013;108(2):240-248.
19. PCV13 (pneumococcal conjugate) vaccine. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/vpd-vac/pneumo/vac-PCV13-adults. htm. Published September 29, 2014. Updated September 3, 2015. Accessed August 16, 2016.
20. Lee CK, Kim HS, Ye BD, et al; Korean Association for the Study of Intestinal Diseases (KASID) Study. Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine. J Crohns Colitis. 2014;8(5):384-391.
21. Melmed GY, Agarwal N, Frenck RW, et al. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease. Am J Gastroenterol. 2010;105(1):148-154.
22. Matheny SC, Kingery JE. Hepatitis A. Am Fam Physician. 2012;86(11):1027-1034.
23. Hepatitis A vaccination. Centers for Disease Control and Prevention. http:// www.cdc.gov/vaccines/vpd-vac/hepa/. Published July 25, 2014. Updated February 3, 2016. Accessed August 16, 2016.
24. Park SH, Yang SK, Park SK, et al. Efficacy of hepatitis A vaccination and factors impacting on seroconversion in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2014;20(1):69-74.
25. Hou JK, Velayos F, Terrault N, Mahadevan U. Viral hepatitis and inflammatory bowel disease. Inflamm Bowel Dis. 2010;16(6):925-932.
26. Ben Musa R, Gampa A, Basu S, et al. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol. 2014;20(41):15358-15366.
27. Belle A, Baumann C, Bigard MA, et al. Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases. Eur J Gastroenterol Hepatol. 2015;27(8):877-881.
28. Gisbert JP, Villagrasa JR, Rodríguez-Nogueiras A, Chaparro M. Efficacy of hepatitis B vaccination and revaccination and factors impacting on response in patients with inflammatory bowel disease. Am J Gastroenterol. 2012;107(10):1460-1466.
29. Allegretti JR, Barnes EL, Cameron A. Are patients with inflammatory bowel disease on chronic immunosuppressive therapy at increased risk of cervical high-grade dysplasia/cancer? A meta-analysis. Inflamm Bowel Dis. 2015;21(5):1089-1097.
30. Rungoe C, Simonsen J, Riis L, Frisch M, Langholz E, Jess T. Inflammatory bowel disease and cervical neoplasia: a population-based nationwide cohort study. Clin Gastroenterol Hepatol. 2015;13(4):693-700.e1.
31. Advisory Committee on Immunization Practices. Recommended adult immunization schedule: United States, 2009. Ann Intern Med. 2009;150(1):40-44.
32. Meningococcal vaccination. Centers for Disease Control and Prevention. http://www.cdc.gov/vaccines/vpd-vac/mening/. Published June 11, 2015. Updated October 22, 2015. Accessed August 16, 2016.
33. Brogan MD, Shanahan F, Oliver M, Stevens RH, Targan SR. Defective memory B cell formation in patients with inflammatory bowel disease following tetanus toxoid booster immunization. J Clin Lab Immunol. 1987;24(2):69-74.
34. Nielsen HJ, Mortensen T, Holten-Andersen M, Brünner N, Sørensen S, Rask-Madsen J. Increased levels of specific leukocyte-and platelet-derived substances during normal anti-tetanus antibody synthesis in patients with inactive Crohn disease. Scand J Gastroenterol. 2001;36(3):265-269.
35. Kim DK, Bridges CB, Harriman KH; Advisory Committee on Immunization Practices (ACIP), ACIP Adult Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedule for adults aged 19 years or older - United States, 2016. Am J Transplant. 2016;16(6):1930-1932.
36. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L. Measles, mumps, and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1998;47(RR-8):1-57.
37. Long MD, Gulati A, Wohl D, Herfarth H. Immunizations in pediatric and adult patients with inflammatory bowel disease: a practical case-based approach. Inflamm Bowel Dis. 2015;21(8):1993-2003.
38. Tsai SY, Yang TY, Lin CL, Tsai YH, Kuo CF, Kao CH. Increased risk of varicella zoster virus infection in inflammatory bowel disease in an Asian population: a nationwide population-based cohort study. Int J Clin Pract. 2015;69(2):228-234.
39. Ham M, Cullen G, Cheifetz AS. Varicella zoster virus infection in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013;9(1):56-58.
40. Kotton CN. Nailing down the shingles in IBD. Inflamm Bowel Dis. 2007;13(9):1178-1179.
41. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40.
42. Fatahzadeh M, Schwartz RA. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J Am Acad Dermatol. 2007;57(5):737-763.
43. Gupta G, Lautenbach E, Lewis JD. Incidence and risk factors for herpes zoster among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006;4(12):1483-1490.
44. ClinicalTrials.gov. Safety and effectiveness study of the live zoster vaccine in anti-TNF users (VERVE). https://clinicaltrials.gov/ct2/show/NCT02538757. Identifier: NCT02538757. Accessed August 16, 2016.
45. Travelers' health: destinations. Centers for Disease Control and Prevention. http://wwwnc.cdc.gov/travel/destinations/list.aspx. Accessed August 16, 2016.
46. International travel and health: traveller vaccinations. World Health Organization. http://www.who.int/ith/updates/20110427/en/. Accessed August 16, 2016.
47. Feder HM Jr, Mansilla-Rivera K. Fever in returning travelers: a case-based approach. Am Fam Physician. 2013;88(8):524-530.
48. Travelers' health: yellow book homepage. Centers for Disease Control and Prevention. http://wwwnc.cdc.gov/travel/page/yellowbook-home-2014. Published July 31, 2013. Updated November 13, 2015. Accessed August 16, 2016.
49. Zanetti AR, Van Damme P, Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine. 2008;26(49):6266-6273.
50. Di Palma JA, Farraye FA. Crohn's disease: the first visit. Gastroenterol Hepatol (N Y). 2011;7(3):163-169.
51. Huth K, Benchimol EI, Aglipay M, Mack DR. Strategies to improve influenza vaccination in pediatric inflammatory bowel disease through education and access. Inflamm Bowel Dis. 2015;21(8):1761-1768.
52. Parker S, Chambers White L, Spangler C, et al. A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD. Inflamm Bowel Dis. 2013;19(9):1809-1814.
53. Reich JS, Miller HL, Wasan SK, et al. Influenza and pneumococcal vaccination rates in patients with inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2015;11(6):396-401.
54. Lee NS, Pola S, Groessl EJ, Rivera-Nieves J, Ho SB. Opportunities for improvement in the care of patients hospitalized for inflammatory bowel disease-related colitis. Dig Dis Sci. 2016;61(4):1003-1012.
55. Lee AJ, Kraemer DF, Smotherman C, Eid E. Providing our fellows in training with education on inflammatory bowel disease health maintenance to improve the quality of care in our health care system. Inflamm Bowel Dis. 2016;22(1):187-193.
56. Sapir T, Moreo K, Carter JD, Greene L, Patel B, Higgins PD. Continuing medical education improves gastroenterologists' compliance with inflammatory bowel disease quality measures. Dig Dis Sci. 2016;61(7):1862-1869.
57. Greene L, Sapir T, Moreo K, Carter JD, Patel B, Higgins PD. Impact of quality improvement educational interventions on documented adherence to quality measures for adults with Crohn's disease. Inflamm Bowel Dis. 2015;21(9):2165-2171.
58. Karr JR, Lu JJ, Smith RB, Thomas AC. Using computerized physician order entry to ensure appropriate vaccination of patients with inflammatory bowel disease. Ochsner J. 2016;16(1):90-95.